SCYNEXIS Inc.
SCYX | NASDAQ
$4.83
+$0.43 (+9.77%)
Sep 22, 2026, 2:41 PM ET · Market open
Company Profile
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Key Executives
| Name | Position |
|---|---|
| David Gonzalez Angulo | Chief Executive Officer, President & Director |
| Ivor Macleod | Chief Financial Officer |
| Scott Sukenick | Chief Legal Officer & Corporate Secretary |
| Daniella Gigante | Vice President of Human Resources & Information Technology |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 10, 2026 | S-8 | Filing |
| Aug 10, 2026 | 10-Q | Quarterly Report |
| Jul 20, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jul 08, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jun 30, 2026 | 4 | Filing |
| Jun 30, 2026 | 4 | Filing |
| Jun 30, 2026 | 4 | Filing |
SCYNEXIS Inc.
| Country | United States |
| IPO Date | May 1, 2014 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Employees | 18 |
| CEO | David Angulo |
Contact Details
1 Evertrust Plaza Jersey City,
New Jersey 07302-6548 United States
Stock Details
| Ticker Symbol | SCYX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001178253 |
| CUSIP Number | 811292309 |
| ISIN Number | US8112923094 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove SCYX